Expert Adviser:

Stacey’s background, including a Ph.D. in cancer biology from Stanford University and years of consulting experience, are invaluable to her Small Cell Lung Cancer clients. Through the ONCrg Advisory services, you can contact Stacey directly for personalized answers to non-proprietary questions, targeted analyses, and custom insights in Small Cell Lung Cancer.   More

SCLC Oncology Resources

Medical Conference Coverage:

Analysts cover major SCLC Conferences and deliver expert analysis of noteworthy scientific, clinical, and commercial changes. Need for better therapy for SCLC is huge, with 5-year survival of ~30% overall and ~2% for metastatic disease. Novel agents are emerging with promising efficacy and the treatment landscape is likely to evolve dramatically over the next 3-5 years.   More

Competitive Landscape Analysis:

Chemotherapy remains the backbone of treatment for SCLC: initial response rates are high, but often not durable. Novel approaches including targeted therapies, immunotherapies, and antibody-drug conjugates showing promise are addressed. Quarterly coverage delivers profiles across the entire competitive landscape, providing valuable analytics of drugs in all phases of development.   More

Monthly Surveillance Reports:

ONC Sentinel provides vigilant monitoring of rapidly evolving scientific, clinical, and commercial activities in oncology. ONCrg experts deliver incisive commentaries on current news events to inform subscribers each month, preparing them to respond wisely to ever-changing market conditions.   More